Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 264,516 shares at $52.35 ($13.8M) on 2022-04-19, disclosed to the SEC on 2022-04-20.
Open-market sale of $13.8M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.14 | 4,195 | $219K | 1.6% |
| 2 | $52.14 | 4,195 | $219K | 1.6% |
| 3 | $52.35 | 97,886 | $5.1M | 37.0% |
| 4 | $52.35 | 97,886 | $5.1M | 37.0% |
| 5 | $52.14 | 30,177 | $1.6M | 11.4% |
| 6 | $52.14 | 30,177 |
| $1.6M |
| 11.4% |
| Total | $52.30 avg | 264,516 | $13.8M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |